drugset / Trial / NCT03351686

Tranexamic Acid in Preventing Postpartum Hemorrhage in High Risk Pregnancies During Elective Cesarean Section

NCT03351686

Phase 2/3 Completed 140 enrolled Mansoura University
RandomizedParallel-groupSingle-blindPrevention

Summary

postpartum hemorrhage (PPT) represents one of the major causes of maternal mortality . Tranexamic acid is used in many studies in management of PPH in combination with ecobolics. this study aims to evaluate the possible value of the use of tranexamic acid in prevention of postpartum hemorrhage .

Timeline

Start
2016-08-01
Primary completion
2017-04-15
Completion
2017-04-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 1 g Intravenous

Indications

No indication recorded.